Wednesday, 13 November 2019

Medical Tourism Market 2019- Latest Trends and Industry Insight by Forecast to 2023

Medical Tourism Market Research Report, by Treatment Type (Orthopedic/Spine Treatments, Oncology/Cancer Treatments, Cosmetic Treatments, Cardiovascular Treatments, Dental Treatments, Fertility/IVF Treatments, others) - Global Forecast Till 2023

Medical Tourism Market Report Overview

Increasing costs of treatments for chronic diseases and other kinds of treatment have been highly encouraging of medical tourism. It has been a common practice in an effort to procure good treatment at lower costs. Developing economies around the world offer high-quality medical treatments which attract patients from other parts of the world. Market Research Future has published its newest report on the global medical tourism market which reveals an expected and promising CAGR of  21.4% during the forecast period from 2017 to 2023. The market was found to be valued at USD 70,836.9 Mn at the start of the forecast period and is likely to grow to reach an impressive USD 226,762.7 Mn by the end of 2023.


In the US, an angioplasty treatment would cost well over USD 55,000. However, in India, the cost is a fraction of the price as USD 3,300. The drastic difference in costs has led patients in developed countries with high healthcare costs to seek treatment in countries which are emerging rapidly and have a similar medical infrastructure. The reduces waiting time for treatment in these countries is also a significant factor driving growth for the global market. Timely treatment is the key to speedy recovery. However, the prevalence of chronic diseases in some developed countries has resulted in waiting lists for treatments. These waiting lists can easily be skipped via medical tourism. Developing countries are positioning themselves as medical tourism hubs with plenty of support from local governments, thus increasing market growth. Investments in healthcare sectors of these countries have ensured high-quality treatments at comparatively low prices. Language barriers and long travel times are expected to work against market growth and challenge the global medical tourism market.\
For the scope of research, the report offers a comprehensive analysis of the global medical tourism market.
Market Segmentation
The global medical tourism market is segmented on the basis of type. This is divided into neurology/neurosurgery treatments, orthopedic/spine treatments, fertility/IVF treatments, cosmetic treatments, cardiovascular/cardiology treatments, oncology/cancer treatments, and dental treatments. Among these, The cosmetic treatments market is the most lucrative segment with a high demand for facial rejuvenation and breast reconstruction treatments. The cost-efficient prices at medical tourism destinations for cosmetic procedures drive the segment’s growth.
Regional Analysis
The Asia Pacific, due to a high concentration of developing economies has a 43.7% share of the market making it the market leader by regional assessment. Investments in technological advancements and state of the art medical machinery are augmenting market growth. Moreover, The region includes South Korea which is a highly popular destination for cosmetic procedures. The APAC is expected to grow at a highly promising CAGR of 22% during the forecast period. Eastern and Central Europe also represent an important regional segment which is growing rapidly and is expected to establish itself as a medical tourism destination over the forecast period.
Key Players
Noted market players that are included in the report are Asklepios Kliniken Verwaltungsgesellschaft mbH, Shouldice Hospital, Bangkok Hospital, Bumrungrad International Hospital, Samitivej PCL, CHRISTUS MUGUERZA, Clemenceau Medical Center, Anadolu Medical Center, Prince Court Medical Centre, Fortis Healthcare, Gleneagles Global Hospitals Group, and Schoen-Kliniken. These market players are extensively profiled in MRFR’s competitive analysis.

Latest Industry News
  • Abu Dhabi’s Department of Culture and Tourism has just signed an MOU with the Medical Tourism Association to partner in its efforts to establish itself as a high-quality medical tourism destination
  • Cancun, Mexico, has begun development of “Health City” with the help of third-party The location of the project is situated 10 minutes from the airport and aims to increase medical tourism activities.

List Of Table 
TABLE 1 GLOBAL MEDICAL TOURISM MARKET SHARE BY TREATMENT TYPE, 2014-2023 (USD MILLION) 26
TABLE 2 GLOBAL MEDICAL TOURISM MARKET SHARE FOR ORTHOPEDIC/SPINE TREATMENTS, 2014-2023 (USD MILLION) 27
TABLE 3 GLOBAL MEDICAL TOURISM MARKET SHARE FOR ONCOLOGY/CANCER TREATMENTS, 2014-2023 (USD MILLION) 28
TABLE 4 GLOBAL MEDICAL TOURISM MARKET SHARE FOR COSMETIC TREATMENTS, 2014-2023 (USD MILLION) 29
TABLE 5 GLOBAL MEDICAL TOURISM MARKET SHARE FOR CARDIOVASCULAR/CARDIOLOGY TREATMENTS, 2014-2023 (USD MILLION) 30
TABLE 6 GLOBAL MEDICAL TOURISM MARKET SHARE FOR DENTISTRY TREATMENTS, 2014-2023 (USD MILLION) 30
TABLE 7 GLOBAL MEDICAL TOURISM MARKET SHARE FOR NEUROLOGY/NEUROSURGERY TREATMENT, 2014-2023 (USD MILLION) 31
TABLE 8 GLOBAL MEDICAL TOURISM MARKET SHARE FOR FERTILITY/IVF TREATMENTS, 2014-2023 (USD MILLION) 32
TABLE 9 GLOBAL MEDICAL TOURISM MARKET SHARE BY REGION, 2014-2023 (USD MILLION) 35
TABLE 10 AMERICAS MEDICAL TOURISM MARKET SHARE BY REGION, 2014-2023 (USD MILLION) 36

Latest Trending Report Boom In Health Care Industry 




Analysis Period
  • Base Year – 2016
  • Projection Period – From 2017 to 2023
  • Market Denomination – USD Million
  • Conversion Rate – Considered as per the respective financial years
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312

Tuesday, 12 November 2019

Radiopharmaceutical Market - Trends insights and Forecas t o 2023

Market Highlights
As the healthcare industry is moving towards the personalized approaches, the role of radiopharmaceutical is also increasing. The radiopharmaceutical is acting as an all-rounder radiopharmaceutical from diagnosis to treatment for various chronic diseases such as cancers and other neurological disorders, which has provided an impetus to the market. Demand for radiopharmaceuticals is growing due to raising awareness about availability of radiation and radioisotopes in medicine, particularly for diagnosis and therapy for various chronic conditions. In developed countries about one person in 50 uses diagnostic nuclear medicine every year, and the demand for therapy with radioisotopes is about one-tenth of this. Radiopharmaceuticals use radiation to provide diagnostic information about the functioning of a person's specific organs while radiotherapy can be used to treat some medical conditions, especially cancer, used to weaken or destroy particular targeted cells.  

Major Players in the Radiopharmaceutical Market
Some of the key players in this market are Jubilant Life Sciences Ltd., Siemens AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Cardinal Health Inc., Medtronic, General Electric Company (GE Healthcare), Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., Mallinckrodt Pharmaceuticals, Nordion, Inc., Canadian Nuclear Laboratories (CNL), Bracco Diagnostic Inc., IBA Dosimetry GmbH, Avid Radiopharmaceuticals and few others.

Market Segmentation
The global radiopharmaceutical market is segmented by type, type of test, application, route of administration, and end user.
By type, it is segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals. Diagnostic type radiopharmaceutical is further sub-segmented into SPECT radiopharmaceutical and PET radiopharmaceutical. Therapeutic type radiopharmaceutical is further sub-segmented into beta emitters, alpha emitters, brachytherapy. SPECT radiopharmaceutical is further sub-segmented into Technetium-99m, Thallium-201, Iodine-123, and others. PET radiopharmaceutical is further sub-segmented into F-18, Rubidium-82, and others. While, beta emitters are sub-segmented into Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177, and others. And, brachytherapy is sub-segmented into Iodine-125, Iridium-192, Cesium-131, and others.
By type of test, it is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan and others. Whereas, a bone scan is further sub-segmented into Technetium-99m 1st, fluoride-18 2nd, and others. Myocardial Perfusion Scan, Type is sub-segmented into Technetium-99m, Thallium-201, Rubidium-82, and others. The lung scan by type is segmented into Xenon-133, Krypton-81m, and others. And, White blood cell Scan is sub-segmented into Indium-111 and others.
By application, it is segmented into oncology, cardiology, neurology, urology, and others. Oncology segment is further segmented into following applications; prostate cancer, bone cancer, breast cancer and others. Cardiology segment is further segmented into following applications; coronary artery disease, cardiomyopathy and others. Neurology segment is further segmented into following applications such as traumatic brain injury, stroke, Alzheimer’s disease and others. Urology is sub-segmented into acute pyelonephritis, congenital renal anomalies, and others.
By Route of Administration, it is segmented into oral, intravenous and others.
By End User, it is segmented into hospitals, diagnostic centers, research institutes and others.

Regional Analysis
The global radiopharmaceutical market is segmented into four major regions including Americas, Europe, Asia Pacific and the Middle East & Africa. Among these, Americas and Europe will continue to present lucrative growth opportunities for market players during the forecast period. Currently, these two regions collectively account for the largest share of the market and the trend is likely to continue over the next couple of years. Higher healthcare spending and existence a robust healthcare system system in these regions is reflecting favorably on the market. In Asia Pacific, increased focus on improving the quality of healthcare services is auguring well for market players operating in the region. During the review period, the market in the region is expected to capture a strong CAGR.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:
Market Research Future
+1 646 845 9312